Orthofix announced that Lucas Vitale has joined the company in the newly created role of chief people and business operations officer. Vitale most recently served as the chief human resources officer, or CHRO, at ReNAgade Therapeutics, a venture backed pharmaceutical company, and prior to that, he served as the CHRO at Berkeley Lights/PhenomeX.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on OFIX:
- Orthofix price target raised to $15 from $12 at Roth MKM
- New Debt & Financing Risk for Orthofix International – What’s the Latest?
- Orthofix sees FY24 revenue $785M-$795M, consensus $798.6M
- Orthofix reports Q4 adjusted EBITDA $19.6M vs. $10.0M last year
- Orthofix International’s Strategy for Investor Engagement
